Diagnostic News and Research

RSS

Prevalence of heart failure is higher in patients with COPD, finds study

As if increased risks of high blood pressure, respiratory infections, lung cancer and even depression weren't enough, researchers say patients with chronic obstructive pulmonary disease (COPD) have another complication to worry about: heart failure.

19 May 2014

Researchers identify heart-specific form of protein that protects against irregular heartbeats

Researchers at the Cedars-Sinai Heart Institute have identified a heart-specific form of a protein, BIN1, responsible for sculpting tiny folds in pockets that are present on the surface of heart muscle cells.

19 May 2014

MD Anderson Cancer Center, Concord Medical sign consulting agreement for cancer hospital projects

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company"), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced it has engaged The University of Texas MD Anderson Cancer Center ("MD Anderson") as a consultant for its cancer hospital projects under planning in Shanghai and Beijing.

16 May 2014

Shark antibodies reveal evolutionary principles of immunoglobulins

Custom-tailored antibodies are regarded as promising weapons against a multitude of serious illnesses. Since they can accurately recognize specific structures on the surface of viruses, bacteria or cancer cells, they are already being deployed successfully in cancer diagnostics and therapy, as well as against numerous other diseases. The stability of the sensitive antibodies is a decisive factor in every step, from production and storage to therapeutic application.

15 May 2014

Corgenix announces that Randox received CE Mark notification for TxBCardio Assay

Corgenix Medical Corporation announced in collaboration with Randox Laboratories that Randox has been granted CE Mark notification for its TxBCardio™ Assay.

From Randox Laboratories Ltd. 15 May 2014

VisionGate develops LuCED test for early detection of lung cancer

VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.

15 May 2014

Virtualscopics reports record revenues in first quarter 2014

VirtualScopics, Inc., a leading provider of quantitative imaging solutions, today reported the financial results for the first quarter ended March 31, 2014.

15 May 2014

Researchers use mobile phone data to help combat malaria more effectively

An international study led by the University of Southampton and the National Vector-borne Diseases Control Programme (NVDCP) in Namibia has used mobile phone data to help combat malaria more effectively.

15 May 2014

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

Epilepsy is a group of neurological disorders often characterized by seizures and cognitive impairment due to electrical disturbances in the brain.

From Quest Diagnostics 14 May 2014

Global market for noninvasive brain monitors to exceed US $250 million in 2019

Several companies are pursuing noninvasive monitors capable of rendering and reporting relative values of key brain health indicators, including intracranial pressure (ICP), cerebral tissue oxygenation and cerebral blood flow, without the need to disturb the cranium.

14 May 2014

Salk scientists explore earliest detectable changes in the brain that lead to schizophrenia

Using new stem cell technology, scientists at the Salk Institute have shown that neurons generated from the skin cells of people with schizophrenia behave strangely in early developmental stages, providing a hint as to ways to detect and potentially treat the disease early.

14 May 2014

Researchers use molecular diagnostic methods to detect cancer

The ABC Medical Center, located in Mexico City, implemented various molecular diagnostic methods that can detect the genetic alterations in several types of cancer, so they can select a personalized therapy for each patient and direct it against the mutated genes that cause disease.

13 May 2014

New breakthrough offers easier way of detecting pathogenic bacteria outside clinical setting

The breakthrough, published in the journal Nature Materials, could offer an easier way of detecting pathogenic bacteria outside of a clinical setting and could be particularly important for the developing world, where access to more sophisticated laboratory techniques is often limited.

13 May 2014

2 genes work together to drive most lethal forms of prostate cancer

Two genes work together to drive the most lethal forms of prostate cancer, according to new research from the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center (CUMC).

13 May 2014

Molecular imaging and multimodality: an interview with Professor Silvio Aime, University of Turin

Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.

From Bruker BioSpin Group 12 May 2014

Longer looks: Understanding downsides of saturated fat, sugar; will innovation save U.S. health care system?

The streetlights in Buenos Aires are considerably dimmer than they are in New York, one of the many things I learned during my family's six-month stay in Argentina. The front windshield of the rental car, aged and covered in the city's grime, further obscured what little light came through. When we stopped at the first red light after leaving the hospital, I broke two of my most important marital promises. I started acting like my wife's doctor, and I lied to her. I had just taken the PET scan, the diagnostic X-ray test, out of its manila envelope (Dr. Peter B. Bach, 5/6).

9 May 2014

Veracyte's revenue increases 71% to $7.5 million in Q1 2014

Veracyte, Inc. today reported financial results for the first quarter ended March 31, 2014, and provided an update on recent business progress. For the first quarter of 2014, revenue was $7.5 million, an increase of 71%, compared to $4.4 million for the first quarter of 2013.

9 May 2014

Clovis Oncology reports net loss of $30.7 million for first quarter 2014

Clovis Oncology, Inc. reported financial results for its first quarter ended March 31, 2014, and provided an update on the Company's clinical development programs for the rest of 2014.

9 May 2014

UBM Canon's MD+DI wins 2014 MAGGIE Award from Western Publishing Association

UBM Canon's MD+DI (Medical Device and Diagnostic Industry), the medtech industry's comprehensive source for news, analysis, and in-depth information for 35 years, was recently honored as a 2014 MAGGIE Award winner at the Western Publishing Association's 63rd Annual MAGGIE Awards in the category of Best Cover (Circulation Under 50,000)/Trade for its August 2013 issue.

8 May 2014

NeoGenomics selects Aurora as primary partner for molecular testing

NeoGenomics, Inc., a leading provider of cancer-focused genetic and molecular testing services, announced today that it has been selected by Aurora Diagnostics to be its primary partner for molecular testing at each of Aurora's 19 specialized anatomic pathology laboratories in the United States.

8 May 2014

Diagnostic News and Research

Prevalence of heart failure is higher in patients with COPD, finds study

Researchers identify heart-specific form of protein that protects against irregular heartbeats

MD Anderson Cancer Center, Concord Medical sign consulting agreement for cancer hospital projects

Shark antibodies reveal evolutionary principles of immunoglobulins

Corgenix announces that Randox received CE Mark notification for TxBCardio Assay

VisionGate develops LuCED test for early detection of lung cancer

Virtualscopics reports record revenues in first quarter 2014

Researchers use mobile phone data to help combat malaria more effectively

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

Global market for noninvasive brain monitors to exceed US $250 million in 2019

Salk scientists explore earliest detectable changes in the brain that lead to schizophrenia

Researchers use molecular diagnostic methods to detect cancer

New breakthrough offers easier way of detecting pathogenic bacteria outside clinical setting

2 genes work together to drive most lethal forms of prostate cancer

Molecular imaging and multimodality: an interview with Professor Silvio Aime, University of Turin

Longer looks: Understanding downsides of saturated fat, sugar; will innovation save U.S. health care system?

Veracyte's revenue increases 71% to $7.5 million in Q1 2014

Clovis Oncology reports net loss of $30.7 million for first quarter 2014

UBM Canon's MD+DI wins 2014 MAGGIE Award from Western Publishing Association

NeoGenomics selects Aurora as primary partner for molecular testing

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News